Figure 4. SRPK1-KD reduces tumour growth in PC3 xenografts in nude mice.
A. Quantitations of the tumour volumes in control and SRPK1-KD mice. B. Examples of tumour growth in both mice groups (tumours outlined in black). C. Examples of microscopic fields of control and SRPK1-KD tumours stained for CD31. Arrows indicate blood vessels. D. Quantitation of microvessel density in control and SRPK1-KD tumours. E. Western blot analysis of SRPK1 and VEGF in duplicate tumours from control and SRPK1-KD groups